MICHAEL JAMES OVERMAN to TOR Serine-Threonine Kinases
This is a "connection" page, showing publications MICHAEL JAMES OVERMAN has written about TOR Serine-Threonine Kinases.
Connection Strength
0.017
-
Target-based therapeutic matching in early-phase clinical trials in patients with advanced colorectal cancer and PIK3CA mutations. Mol Cancer Ther. 2013 Dec; 12(12):2857-63.
Score: 0.017
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.